T1	Participants 89 140	prophylaxis of postoperative deep venous thrombosis
T2	Participants 906 919	United States
T3	Participants 1426 1528	Eight hundred and eighty eight patients were entered into this trial and 744 (85%) completed the study
T4	Participants 1071 1239	General surgical patients including those undergoing noncardiac thoracic and pelvic operations who were identified at moderate to high risk for postop DVT were included
